Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines

详细信息    查看全文

• 作者：Valentina Agnolon^a ; ^b ; Cristina Bruno^a ; ^c ; Bruno Galletti^a ; Elena Mori^a ; Mildred Ugozzoli^d ; Carlo Pergola^a ; Derek T. O&rsquo ; Hagan^d ; Barbara C. Baudner^a ; ^{barbara.c.baudner@gsk.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Luminex technology ; Multiplex ; Aluminum hydroxide ; Combination vaccine ; Acellular pertussis
• 刊名：Vaccine
• 出版年：2016
• 出版时间：17 February 2016
• 年：2016
• 卷：34
• 期：8
• 页码：1040-1046
• 全文大小：719 K

文摘

Vaccines characterization is required to ensure physical, chemical, and biological integrity of antigens and adjuvants. Current analytical methods mostly require complete antigen desorption from aluminum-based adjuvants and are not always suitable to distinguish individual antigens in multivalent formulations. Here, Luminex technology is proposed to improve the analytics of vaccine characterization. As proof of concept, TdaP (tetanus, diphtheria and acellular pertussis) combination, adjuvanted with aluminum hydroxide, was chosen as model formulation to quantify and determine the level of adsorption of acellular pertussis (aP) antigens onto adjuvant surface at the same time. The assay used specific antibodies bound to magnetic microspheres presenting unique digital signatures for each pertussis antigen, allowing the simultaneous recognition of respective antigens in the whole vaccine, avoiding laborious procedures for adjuvant separation. Accurate and reproducible quantification of aP antigens in TdaP vaccine has been achieved in the range 0.78–50 ng/mL, providing simultaneously information on antigen identity, quantity, and degree of adsorption to aluminum hydroxide. The current study could further be considered as a model to set up in vitro potency assays thus supporting the replacement of animal tests accordingly to the 3Rs concept.